Skip to main content

Alterity Therapeutics Limited - American Depositary Shares (NQ:ATHE)

4.830 -0.180 (-3.59%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 16, 2025 Add to My Watchlist

Price and Volume

Detailed Quote
Volume 31,301
Open 4.920
Bid (Size) 4.750 (1)
Ask (Size) 5.060 (11)
Prev. Close 5.010
Today's Range 4.800 - 5.170
52wk Range 1.001 - 7.000
Shares Outstanding 2,084,016,678
Dividend Yield N/A

Performance

YTD
+29.5%
+29.5%
1 Month
+8.5%
+8.5%
3 Month
+4.8%
+4.8%
6 Month
+38.0%
+38.0%
1 Year
+286.4%
+286.4%

More News

Read More

Frequently Asked Questions

Is Alterity Therapeutics Limited - American Depositary Shares publicly traded?
Yes, Alterity Therapeutics Limited - American Depositary Shares is publicly traded.
What exchange does Alterity Therapeutics Limited - American Depositary Shares trade on?
Alterity Therapeutics Limited - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Alterity Therapeutics Limited - American Depositary Shares?
The ticker symbol for Alterity Therapeutics Limited - American Depositary Shares is ATHE on the Nasdaq Stock Market
What is the current price of Alterity Therapeutics Limited - American Depositary Shares?
The current price of Alterity Therapeutics Limited - American Depositary Shares is 4.830
When was Alterity Therapeutics Limited - American Depositary Shares last traded?
The last trade of Alterity Therapeutics Limited - American Depositary Shares was at 10/16/25 04:00 PM ET
What is the market capitalization of Alterity Therapeutics Limited - American Depositary Shares?
The market capitalization of Alterity Therapeutics Limited - American Depositary Shares is 10.07B
How many shares of Alterity Therapeutics Limited - American Depositary Shares are outstanding?
Alterity Therapeutics Limited - American Depositary Shares has 10B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.